我們已在上線！進一步了解

SBC Medical Group

SBC

市值 US$5.31億

5.16 USD

-0.14

2.64%

收盤時已更新 10月16日下午4:00 EDT

1天

-2.64%

5天

-5.32%

1個月

15.18%

3個月

62.78%

6個月

16.74%

今年迄今

19.17%

1年

23.74%

5年

-48.19%

10年

-48.19%

關於： SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.

員工： 863

工業顧問服務

新聞

正面

中性

負面

市場情緒 3個月

正面 18.2%

中性 72.7%

負面 9.1%

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026

IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in October 2026.

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026

SBC Medical to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Irvine, California--(Newsfile Corp. - September 10, 2026) - SBC Medical Group Holdings Incorporated (NASDAQ: SBC) ("The Company" or "SBC Medical"), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in the upcoming 3 rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Hikaru Fukui, Head of IR department of SBC Medical, will be presenting on the company's recent milestones and future growth strategy.

SBC Medical to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical will be conducting a Non-Deal Roadshow (NDR) and participating in several investor conferences throughout September 2026.

SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026

SBC Medical Group Re-Accelerates Growth as EBITDA Surges 32% in Q2

SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 following structural reforms undertaken in 2025, with profit growth exceeding revenue growth as the company expanded management services revenue and increased service fees.

SBC Medical Group Re-Accelerates Growth as EBITDA Surges 32% in Q2

Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated

NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research quarterly update on SBC Medical Group Holdings Incorporated (NASDAQ:SBC), which, together with its subsidiaries, provides management services to cosmetic treatment centers via a franchise model in Japan, Vietnam, Thailand, Singapore, and the United States. This release is being issued as an updated version of EGR's previously published press release regarding its Q2:26 Quarterly Update on SBC Medical Group Holdings Incorporated.

Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated

Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2026 / Emerging Growth Research today announced the release of its Q2:26 Quarterly Update Report on SBC Medical Group Holdings (NASDAQ:SBC), reiterating its Buy rating and increasing its 12-month price target to $11.00 from $10.00. The Quarterly Update highlights SBC Medical Group's return to revenue growth in 2026 following the completion of pricing-related headwinds experienced during 2025, while emphasizing the Company's strong cash position, expanding clinic footprint, continued international expansion, and new AI-driven growth initiatives.

Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00

SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%

SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 as the company completed structural reforms undertaken in 2025, expanded its clinic network and increased management-services revenue.

SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%

SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call Transcript

SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call Transcript

SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call Transcript

SBC Medical Group Q2 Earnings Call Highlights

SBC Medical Group NASDAQ: SBC said its second-quarter 2026 results reflected a reacceleration in growth following structural reforms undertaken in 2025, with adjusted EBITDA rising faster than revenue despite the effect of a weaker yen on reported results.

SBC Medical Group Q2 Earnings Call Highlights

SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year.

SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

查看新聞排名

價格圖表採用Lightweight Charts™實作